Next Generation/Patient-Focused Value-Based Arrangements: The Policy Steps Ahead

On Thursday, April 16 NEHI convened a virtual meeting on the policy steps needed to bring patient focus to value-based arrangements.

NEHI Vice President of Policy Research Tom Hubbard, facilitated a panel discussion with:

• Derek Asay, Senior Director, Government Strategy, Federal Accounts and Quality,   Eli Lilly and Company
• Patrick Gleason, Senior Director of Health Outcomes, Prime Therapeutics ; Fellow and Director, Academy of Managed Care Pharmacy
• Shawn Bishop, former professional staff member, U.S. Senate Finance Committee

Discussion focused on how appropriate changes in federal policy could bring greater patient focus to value-based arrangements while respecting broader federal goals, such as the goals of the Medicaid Drug Rebate Program and enforcement of the Anti-Kickback Statute. The topics included:

• The role of VBAs as tools for arrangements that meet payer financial goals while ensuring timely access to therapy for patients
• Sharing VBA financial benefits with patients
• Lawmakers’ perceptions of current VBAs and the need to demonstrate patient benefits from VBAs
• Understanding how current Medicaid Best Price reporting constraints  risk-sharing in VBAs, and consequent impact on patients
• The potential for greater application of VBAs to chronic disease treatments
• The need for supportive policy that encourages VBAs linked to non-traditional, patient-centered outcomes metrics, such as patient-reported outcomes metrics.